Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07335341 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 3 to 4v7
  2. Study sites: 2 to 3v6
  3. Study sites: 1 to 2v5
  4. Recruitment opened
    • Primary and study completion pushed from Aug 2026 to Oct 2026
    • Start date changed from estimate of Mar 2026 to Feb 24, 2026
    • Site details revised
    v4
  5. Study sites: 0 to 1
    • Primary and study completion dates: Apr 2026 to Aug 2026
    • Start date: Jan 2026 to Mar 2026
    v3
  6. Re-verified, no change to tracked fieldsv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of Case-Specific Health Care Professional (HCP) Clinical Survey of Liberant™ Thrombectomy System, also known as the Liberant Clinical Assessment, is to collect first-in-human clinical data to confirm the safety and performance of the Medtronic Liberant™ thrombectomy system when used for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems
Trial Details
NCT Number NCT07335341
Lead Sponsor Medtronic Endovascular
Conditions
(from sponsor)		 Venous Embolism of Lower Extremities (Diagnosis), Arterial Embolism and Thrombosis, Acute DVT of Lower Extremity, Chronic DVT of Lower Extremity, DVT, Deep Vein Thrombosis Leg, Thrombus in the Peripheral Venous Vasculature, Peripheral Arterial Disease +3 more
Related terms Arterial Occlusive Diseases, Disease, Peripheral Arterial Disease, Peripheral Vascular Diseases, Thrombosis, Vascular Diseases, Venous Thrombosis
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov